DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration

European Journal of Neuroscience

Volumn 8, Issue 12, 1996, Pages 2511-2520

  Chritin, M ^a,c   Blanchard, V ^b   Raisman Vozari, R ^b   Feuerstein, C ^a   Agid, Y ^b   Javoy Agid, F ^b   Savasta, M ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

6 OHDA induced lesion; Dopaminergic receptors; In situ hybridization; mRNA; Nigrostriatal dopaminergic pathway; Preproenkephalin; Quantitative autoradiography

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MESSENGER RNA; OXIDOPAMINE; PREPROENKEPHALIN; PROTEIN C FOS; RACLOPRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BRAIN INJURY; CELL POPULATION; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; IMAGE ANALYSIS; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; ISOTOPE LABELING; MALE; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SUBSTANTIA NIGRA;

ANIMALS; BINDING SITES; CORPUS STRIATUM; DENERVATION; DOPAMINE; ENKEPHALINS; IMMUNOHISTOCHEMISTRY; MALE; NERVE DEGENERATION; PIPERAZINES; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE;

EID: 0030452995     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.1996.tb01545.x     Document Type: Article

References (57)

1. Agid, Y., Javoy, F. and Glowinski, J. (1973a) Hyperactivity of remaining dopaminergic neurons after partial destruction of the nigrostriatal dopaminergic system in the rat. Nature, 245, 150-151.
2. Agid, Y., Javoy, F., Glowinski, J., Bouvet, D. and Sotelo, C. (1973b) Injection of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificity. Brain Res., 58, 291-301.
3. Agid, Y., Javoy-Agid, F. and Ruberg, M. (1987) Biochemistry of neurotransmitters in Parkinson's disease. In Marsden, C. D. and Fahn, S. (eds), Neurology 2, Movement Disorders. Butterworth, London, UK, pp. 166-230.
4. Ariano, M. A. (1988) Striatal dopamine receptor distribution following chemical lesion of the nigrostriatal pathway. Brain Res., 443, 204-214.
5. Bal, A., Savasta, M., Chritin, M., Mennicken, F., Abrous, D. N., Le Moal, M., Feuerstein, C. and Herman, J. P. (1993) Transplantation of fetal nigral cells reverses the increase of preproenkephalin mRNA levels in the rat striatum caused by 6-OHDA lesion of the dopaminergic pathway, a quantitative in situ hybridization. Mol. Brain Res., 18, 221-227.
6. Barneoud, P., Parmentier, S., Mazadier, M., Miquet, J. M., Boireau, A., Dubedat, P. and Blanchard, J. C. (1995) Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat. Neuroscience, 67, 837-848.
7. Beckstead, R. M., Domesick, V. B. and Nauta, W. J. H. (1979) Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res., 175, 191-217.
8. Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. and Seitelberger, F. (1973) Brain dopamine and the syndromes of Parkinson and Huntington, clinical, morphological and neurochemical correlations. J. Neurol. Sci., 20, 415-455.
9. Blaha, C. D. and Winn, P. (1993) Modulation of dopamine efflux in the striatum following cholinergic stimulation of the substantia nigra in intact and pedunculopontine tegmental nucleus-lesioned rats. J. Neurosci., 13, 1035-1044.
10. Blanchard, V., Chritin, M., Vyas, S., Savasta, M., Javoy-Agid, F., Feuerstein, C., Agid, Y. and Raisman, R. (1995) Long-term induction of tyrosine hydroxylase expression, compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain. J. Neurochem., 64, 1669-1679.
11. Bolam, J. P., Francis, C. M. and Henderson, Z. (1991) Cholinergic input to dopaminergic neurons in the substantia nigra, a double immunocytochemical study. Neuroscience, 41, 483-494.
12. Bolam, J. P. and Smith, Y. (1990) The GABA and substance P input to dopaminergic neurons in the substantia nigra of the rat. Brain Res., 529, 57-78.
13. Bunzow, J. R., Van Tol, H. H. M., Grandy, D. K., Albert, P., Salon, J., Christie M. D., Machida, C. A., Neve, K. A. and Civelli, O. (1988) Cloning and expression of rat D2 dopamine receptor cDNA. Nature, 336, 783-787.
14. 1 receptor supersensitivity in the rat striatum after unilateral 6 hydroxydopamine lesions. Eur. J. Pharmacol., 126, 347-348.
15. Cadet, J. L., Ming Zhu, S. and Angulo, J. A. (1992) Quantitative in situ hybridization evidence for differential regulation of preproenkephalin and dopamine D2 receptor mRNA levels in the rat striatum, effects of unilateral injections of 6 hydroxydopamine. Mol. Brain Res., 12, 59-67.
16. Castaneda, E., Whishaw, I. Q. and Robinson, T. E. (1990) Changes in striatal dopamine neurotransmission assessed by microdialysis following recovery from a bilateral 6-OHDA lesion, variation as a function of lesion size. J. Neurosci., 110, 1847-1854.
17. Chritin, M., Feuerstein, C. and Savasta, M. (1993) Time course changes in striatal levels of DA uptake sites, DA D2 receptor and preproenkephalin mRNAs after nigrostriatal dopaminergic denervation in the rat. Mol. Brain Res., 19, 318-322.
18. Chritin, M., Savasta, M., Mennicken, F., Bal, A., Abrous, D. N., Le Moal, M., Feuerstein, C. and Herman, J.-P. (1992) Intrastriatal dopamine rich implants reverse the increase of dopamine D2 receptor mRNA levels caused by the lesion of the nigrostriatal pathway, a quantitative in situ hybridization study. Eur. J. Neurosci., 4, 663-672.
19. Creese, I., Burt, D. R. and Snyder, S. H. (1977) Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science, 197, 596-598.
20. Dawson, T. M., Dawson, V. L., Gage, F. H., Fisher, L. J., Hunt, M. A. and Wamsley, J. K. (1991) Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra. Exp. Neurol., 111, 282-292.
21. Fornaguera, J., Schwarting, R. K. W., Boix, F. and Huston, J. P. (1993) Behavioral indices of moderate nigro-striatal 6-OHDA lesion. A preclinical Parkinson's model. Synapse, 13, 179-185.
22. Gerfen, C. R., McGinty, J. F. and Young, W. S. (1991) Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neuron: an in situ hybridization histochemical analysis. J. Neurosci., 11, 1016-1031.
23. Giorguieff, M. F., Lefloc'h, M. I., Glowinski, J. and Besson, M. J. (1977) Involvement of presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat. J. Pharmacol. Exp. Ther., 200, 535-544.
24. Giros, B., Sokoloff, P., Martres, M.-P., Riou, J.-F., Emorine, L. J. and Schwartz, J.-C. (1989) Alternative splicing directs the expression of two D2 dopamine receptors isoforms. Nature, 342, 923-926.
25. Graybiel, A. M., Moratalla, M. R. and Robertson, H. A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA, 87, 6912-6916.
26. Guesdon, J. L., Ternynck, T. and Avrameas, S. (1979) The use of avidinbiotin interaction in immunoenzymatic techniques. J. Histochem. Cytochem., 27, 1131-1139.
27. Hefti, F., Enz, A. and Melamed, E. (1985) Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurons by drugs. Neuropharmacology, 24, 19-23.
28. König, J. F. R. and Klippel, R. A. (1963) The Rat Brain. Williams & Wilkins, Baltimore, MD.
29. Le Moine, C., Normand, E., Guitteny, A. F., Fouque, B., Teoule, R. and Bloch, B. (1990) Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. Natl Acad. Sci. USA, 87, 230-234.
30. Manier, M., Abrous, D. N., Feuerstein, C., Le Moal, M. and Herman, J.-P. (1991) Increase of striatal methionin enkephalin content following lesion of the nigrostriatal pathway in adult rats and reversal following the implantation of embryonic dopaminergic neurons, a quantitative immunohistochemical analysis. Neuroscience, 42, 427-439.
31. 1 binding density following mesotelencephalic 6-hydroxydopamine injections, an autoradiographic analysis. Brain Res., 493, 247-257.
32. 3H] GBR 12935. J. Neural Transm., 87, 1-14.
33. Nagatsu, T. (1990) Changes of tyrosine hydroxylase in the Parkinsonian brain and in the brain of MPTP-treated mice as revealed by homospecific activity. Neurochem. Res., 15, 425-429.
34. Nieoullon, A., Cheramy, A. and Glowinski, J. (1977) Interdependance of the nigrostriatal dopaminergic systems on the two sides of the brain in the cat. Science, 198, 416-418.
35. Pasinetti, G. M., Lerner, S. P., Johnson, S. A., Morgan, D. G., Telford, N. A. and Finch, C. E (1989) Chronic lesions differentially decrease tyrosine hydroxylase messenger RNA in dopaminergic neurons of the substantia nigra. Mol. Brain Res., 5, 203-209.
36. Paturle, L., Page, D., Fourrier, O., Vernier, P., Feuerstein, C., Demenge, P. and Scatton, B. (1987) Cortical ablation fails to influence striatal dopamine target cell supersensitivity induced by nigrostriatal denervation in the rat. Brain Res., 402, 383-386.
37. Paxinos, G. and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, New York.
38. Racagni, G., Bruno, F., Cattabeni, E., Maggi, A., Digiuglio, A. M., Parenti, M. and Gropetti, A. (1977) Functional interaction between rat substantia nigra and striatum, GABA and dopamine interaction. Brain Res., 134, 353-358.
39. Reid, M. S., Herrera-Marschitz, M. and Hökfelt, T. (1988) Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P. Eur. J. Pharmacol., 147, 411-420.
40. Riederer, P. and Wuketich, S. (1976) Time course of nigrostriatal degeneration in Parkinson's disease. J. Neural Transm., 38, 277-301.
41. Robertson, G. S., Herrera, D. G., Dragunow, M. and Robertson, H. A. (1989) L-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra. Eur. J. Pharmacol., 159, 99-100.
42. Robinson, T. E. and Whishaw, I. Q. (1988) Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res., 45, 209-224.
43. Robinson, T. E., Castaneda, E. and Whishaw, I. Q. (1990) Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies. Can. J. Psychol., 44, 253-275.
44. Robinson, T. E., Moscary, Z., Camp, D. M. and Wishaw, I. Q. (1994) Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system. J. Neurosci., 14, 2687-2696.
45. Rosen, H., Douglass, S. and Herbert, E. (1984) Isolation and characterization of the rat preproenkephalin gene. J. Biol. Chem., 259, 14309-14313.
46. Sagar, S. M., Sharp, F. R. and Curran, T. (1988) Expression of c-fos protein in brain, metabolic mapping at the cellular level. Science, 240, 1328-1331.
47. 3H]SCH 23390. Brain Res., 375, 291-303.
48. Savasta, M., Dubois, A., Feuerstein, C., Manier, M. and Scatton, B. (1987) Denervation supersensitivity of striatal D2 receptors is restricted to the ventro and dorso lateral regions of the striatum. Neurosci. Lett., 75, 180-186.
49. Savasta, M., Mennicken, F., Chritin, M., Abrous D. N., Feuerstein, C., Le Moal, M. and Herman, J.-P. (1992) Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-OHDA lesion of the nigrostriatal pathway in rats, an autoradiographic study. Neuroscience, 46, 729-738.
50. Shirao, T., Evinger, M. J., Iacovitti, L. and Reis, D. J. (1992) Lesions of nigrostriatal pathway reduce expression of tyrosine hydroxylase gene in residual dopaminergic neurons of substantia nigra. Neurosci. Lett., 141, 208-212.
51. Snyder, G. L., Keller, R. W. and Zigmond, J. (1990) Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine, evidence for compensatory hyperactivity of residual terminals. J. Pharmacol. Exp. Ther., 253, 867-876.
52. Sternberber, L. A. (1974) Enzyme conjugated antibody methods. In Immunocytochemistry. Prentice-Hall, Englewood Cliffs, NJ.
53. Ungerstedt, U. (1968) 6-Hydroxydopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol., 5, 107-110.
54. Ungerstedt, U. and Arbuthnott, G. W. (1970) Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopaminergic system. Brain Res., 24, 485-493.
55. Zigmond, M. J., Acheson, A. L., Stachowiak, M. K. and Stricker, A. M. (1984) Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Arch. Neurol., 41, 856-861.
56. Zigmond, M. J., Schwarzschild, M. A. and Rittenhouse, A. R. (1989) Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Annu. Rev. Neurosci., 12, 415-461.
57. Zigmond, M. J., Abercrombie, E. D., Berger, T. W., Grace, A. A. and Stricker, A. M. (1990) Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci., 13, 290-293.